GRAS Notices
-
GRN No. 399
Preparation of Bacillus coagulans strain GBI-30, 6086 spores
Intended Use: | As an ingredient in baked goods and baking mixes; beverages and beverage bases; breakfast cereals; chewing gum; coffee and tea; condiments and relishes; confections and frostings; dairy product analogs; fruit juices; frozen dairy desserts and mixes; fruit and water ices; gelatins, puddings, and fillings; grain products and pastas; hard candy; herbs, seeds, spices, seasonings, blends, extracts, and flavorings; jams and jellies; milk; milk products; nuts and nut products; plant protein products; processed fruits; processed vegetables and vegetable juices; snack foods; soft candy; soups and soup mixes; sugar; and sweet sauces, toppings, and syrups at a maximum level of approximately 2 x 109 colony forming units per serving |
---|---|
Basis: | Scientific procedures |
Notifier: | Ganeden Biotech, Inc. |
Notifier Address: |
5915 Landerbrook Drive, Suite 304 Mayfield Heights, OH 44124 |
Date of filing: | Aug 23, 2011 |
GRAS Notice (releasable information): | GRN 399 (in PDF) |
Part 2: | GRN 399 amendments (1.2 MB) |
Date of closure: | Jul 31, 2012 |
FDA's Letter: | FDA has no questions |
-